Paper7679331
Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.
Smith DC and 7 others. Cancer Chemother Pharmacol, 1993. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer. Papers, record 7679331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7679331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melphalan | Major topic |
| Prostatic Neoplasms | Major topic |
| Aged | |
| Aged, 80 and over | |
| Chromatography, High Pressure Liquid | |
| Half-Life | |
| Hormones | |
| Humans | |
| Infusions, Intravenous | |
| Male | |
| Middle Aged | |
| Prostate-Specific Antigen |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5T32-CA-09307 | NCI NIH HHS | United States | T32CA009307 | PubMed and NIH | NIH RePORTER |
| P30-A-14236-18 | PHS HHS | United States | PubMed | PubMed | |
| U10-CA-44691 | NCI NIH HHS | United States | U10CA044691 | PubMed and NIH | NIH RePORTER |
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 498,715 | Oral melphalan kinetics. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/498715 | PubMed |
| 2 | 445,500 | Melphalan in metastatic cancer of the prostate: a pilot study. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/445500 | PubMed |
| 3 | 3,948,304 | Pharmacokinetics of high-dose melphalan in children and adults. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3948304 | PubMed |
| 4 | 1,371,564 | Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer. | J Urol | 1992 | https://conductscience.org/library/papers/1371564 | PubMed |
| 5 | 6,861,266 | Pharmacokinetics of melphalan in children following high-dose intravenous injection. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6861266 | PubMed |
| 6 | 630,199 | Prednimustine therapy for advanced prostatic cancer. | Br J Urol | 1978 | https://conductscience.org/library/papers/630199 | PubMed |
| 7 | 125,803 | Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate. | J Urol | 1975 | https://conductscience.org/library/papers/125803 | PubMed |
| 8 | 365,313 | Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial. | Cancer | 1978 | https://conductscience.org/library/papers/365313 | PubMed |
| 9 | 736,979 | Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells. | Biochem Pharmacol | 1978 | https://conductscience.org/library/papers/736979 | PubMed |
| 10 | 4,053,270 | High dose melphalan in children with advanced malignant disease. A pharmacokinetic study. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4053270 | PubMed |
| 11 | 1,984,806 | Cancer statistics, 1991. | CA Cancer J Clin | 1991 | https://conductscience.org/library/papers/1984806 | PubMed |
| 12 | 762,115 | Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro. | J Biol Chem | 1979 | https://conductscience.org/library/papers/762115 | PubMed |
| 13 | 6,840,181 | The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6840181 | PubMed |
| 14 | 4,585,929 | Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate. | Cancer | 1973 | https://conductscience.org/library/papers/4585929 | PubMed |
| 15 | 125,624 | The chemotherapy of urologic cancer. | Cancer | 1975 | https://conductscience.org/library/papers/125624 | PubMed |
| 16 | 3,396,150 | Lack of effect of cisplatin on i.v. L-PAM plasma pharmacokinetics in ovarian cancer patients. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3396150 | PubMed |
| 17 | 7,427,921 | A comparison of melphalan transport in human breast cancer cells and lymphocytes in vitro. | Cancer Lett | 1980 | https://conductscience.org/library/papers/7427921 | PubMed |
| 18 | 3,516,430 | Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3516430 | PubMed |
| 19 | 3,719,900 | Renal function in the elimination of oral melphalan in patients with multiple myeloma. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3719900 | PubMed |
| 20 | 6,436,700 | Leuprolide versus diethylstilbestrol for metastatic prostate cancer. | N Engl J Med | 1984 | https://conductscience.org/library/papers/6436700 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7679331
GET https://conductscience.org/api/papers/v1/7679331/references?page=2